At the MAPS 2022 Global Annual Meeting, we sat down with Riad Dirani, Vice President of Global Health Economics and Outcomes Research at Teva Pharmaceuticals, and Omar Dabbous, Vice President of Global Health Economics and Outcomes Research and Real World Evidence at AveXis to chat about the structure and activities of HEOR within Medical Affairs.
MAPS speaks with Tim Mikhelashvili and Riaz Abbas about innovative approaches to compliant patient education including collaborations with patient associations, peer navigators and the emerging use of social media.
MAPS members represent the full range of Medical Affairs professionals, from those leading or working in large organizations, to those tasked with starting a Medical Affairs function at startup or emerging organizations. Here, MAPS speaks with Lobna Salem, Regional Chief Medical officer Developed Markets& Japan Australia and New Zealand at Viatris, about the process of building Medical Affairs from scratch.
Digital tools power the ability of Medical Affairs teams to generate, analyze and disseminate data to external stakeholders across the product lifecycle, while bringing essential learnings from these stakeholders back to the organization in the form of insights.
This paper explores the Medical Affairs-based medical insights function and and identifies basic operational elements required to establish medical insights as a core strategic MA function.
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
At the MAPS 2022 Global Annual Meeting, MAPS sits down to chat with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about developments in the practice and direction of Medical Affairs in Latin America. Augusto and José are also co-chairs of the MAPS Latin America Chapter.
This webinar will analyze the current state of Medical Affairs in Japan, highlight progress made and provide suggestions on what we can do together to make Medical Affairs in Japan even more effective.
This webinar will be covering:
1.   MA in Japan today: progress and highlights
a.   Leadership requirements in Japan to bring MA to the next level
b.   MA has become more strategic across all companies
c.    What are the competencies required to succeed?
2.   Looking into the future of MA in Japan
a.   How to engage more with Patients/Patient Advocacy groups
b.   How to bring more value to customers, scientific leaders and health systems
c.    How to better engage academia and health authority group through scientific exchange
3.   Opportunities for improving effectiveness
a.   Differentiation of MSL and Medical Rep roles- how are companies differentiating despite the regulations?
MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
As Medical Affairs professionals, it's easy to focus on the tasks that are right in front of us everyday. In this interview with Monica de Abadal, SVP and Head of Medical Affairs, North America we sat down at the MAPS 2022 Global Annual Meeting to take a step back. Here is how Medical Affairs benefits patients and society. Watch the full interview here.